Publications Archive

Universal health coverage, meaning that all individuals and communities can access essential quality health services without suffering financial hardship, has become the top priority of the World Health Organisation. Achieving the ambitious goal of universal health coverage will require more resources, and the better use of existing resources. At the same time, efforts to achieve…

Read Publication >

Clinical trials are a key driver of medical innovation and progress, but scientists have known for decades that the existing evidence base on drugs and medical devices is incomplete and biased due to the opacity of clinical trials. The medical community, the private sector and public bodies all lack access to reliable information on the…

Read Publication >

“Business Principles for Promoting Integrity in the Pharmaceutical Sector in Latin America” (Pharma Integrity Principles), is a set of new principles focused on strengthening ethical standards across the pharmaceutical sector in Latin America, promoting integrity and ethical business practices. The Pharma Integrity Principles for Latin America aim to promote integrity in the pharmaceutical sector and guide…

Read Publication >

TI-PHP’s new report “Making the Case for Open Contracting in Healthcare Procurement”   examines the utility of open contracting in healthcare procurement. The process relies on governments to disclose procurement information to businesses and civil society improves stakeholders’ understanding of procurement processes increasing the integrity, fairness and efficiency of public contracting. In several countries, including…

Read Publication >

Transparency International UK’s Pharmaceuticals & Healthcare Programme provides a response to NHS England’s Managing Conflicts of Interest in the NHS: A Consultation. Click here to access the consultation.  

Read Publication >

From the politician to the patient, corruption is part of doing business in the healthcare sector all over the world. Corruption is pervasive within healthcare to the extent it has become normalised. Information collected from a literature review, key informant interviews, and a survey with healthcare professionals was used to identify the main corruption types in…

Read Publication >

11 true stories about very different people, in very different contexts. But with one common message: change is always possible, even when the odds seem stacked against you. From India to Zimbabwe, these are stories about standing up and fighting back against corruption in health.  

Read Publication >

The Transparency International’s Pharmaceuticals & Healthcare Programme funds national and local projects conducted by TI chapters worldwide. In this project TI Nepal examined the Government of Nepal’s distribution of seventy medicines free of cost to all of its citizens. The research process included a survey to collate the experiences and perception of local citizens and…

Read Publication >

Within the health sector, pharmaceuticals stands out as sub-sector that is particularly prone to corruption. There are abundant examples globally that display how corruption in the pharmaceutical sector endangers positive health outcomes. Whether it is a pharmaceutical company bribing a doctor for prescribing its medicines irrespective of a health need or a government employee facilitating…

Read Publication >

Building on 20 years of experience in this and other sectors, Transparency International UK is taking up the challenge of analysing, understanding and combating corruption in this vital sector. We aim to do so through a coordinated international initiative, working in close coalition with Transparency International national chapters throughout the world and other partners from the…

Read Publication >